Halt Anxiety with Proven Techniques

I am proud to announce that my new book which introduces proven techniques that Halt  Anxiety is now available as a download and as a paperback. This has been a work in progress for four months which is at long last complete.   

My new book introduces simple techniques that calm anxiety and reduce stress when most needed. The techniques: 

  • Are simple to implement 
  • Can be accessed anywhere, anytime in any situation. 
  • Cost nothing
  • Reduce anxiety
  • Calm stress 
  • Help reduce the severity of symptoms

Click below to order the download which will be sent immediately to your computer or phone. 

Download of Halt Anxiety
 8.88

Click below to order the paperback:

Paperback of Halt Anxiety
$10.00

Robert Rodgers PhD
Olympia Washington
Road to Recovery from Parkinsons Disease|
https://www.parkinsonsdisease.me 
877-526-4646 

[

Jump Start to Recovery

Beginning December 3rd I will launch Jump Start to Recovery course to help participants develop a program of recovery to reverse whatever symptoms they currently experience. Content of the course is organized around two key questions:

  1. What causes the symptoms you currently experience?
  2. What in the world can you do to reverse them?
The live sessions continue throughout December 2018 for six (6) live sessions. Replays and notes are available for all classes.

Visit the secure page listed below for more information and to register. Only two registrations remain available until the class will be closed. 

December 2018 Jump Start to Recovery

Jump Start to Recovery includes a bounty of support resources, downloads of many of my books, videos and 24 hours of online lectures in addition to the six live class sessions with me personally.

Robert Rodgers PhD
Road to Recovery from Parkinsons Disease
https://www.parkinsonsdisease.me

2018 Light Therapy Research Findings

2018 Study Finds Light Therapy Reverses Dementia

Light therapy has floated to the top of my list as a promising treatment for dementia and Parkinson’s after reviewing results of my 2018 Parkinsons Recovery holiday survey. A  surprising number of persons reported that light therapy (or photobiomodulation therapy invented by Vielight) had helped them get relief from their Parkinson’s symptoms.

Light therapy is not new. It has been researched under a variety of terms for over 40 years: low level laser therapy or LLLT, laser biostimulation and most recently photobiomodulation. This noninvasive therapy has been used in clinical practices to treat healing-resistant wounds, ulcers, pain and nervous system injuries. More recently it is a therapy that has attracted the attention of researchers as a therapy for Parkinson’s and dementia.

A July 2018 a University of California San Francisco study conducted by Linda Chao PhD offered compelling support for its application to treat dementia. Eight adults diagnosed with dementia participated in the study. Four subjects received 12 weeks of self-administered Photobiomodulation treatments in their homes. Four were assigned to a control group. Treatments were administered using a commercially available device (Vielight Neuro Gamma). Outcome measures were assessed at baseline, 6-weeks, and 12-weeks.

Findings revealed significant improvement in cognition and functional connectivity. Dr. Chao concluded that photobiomodulation therapy is a safe, non-pharmacological therapy that can be used to treat patients in their homes.

Results of this study are indeed impressive. Large samples are typically required for a study to show significance. Despite its small size, this study showed significant results.

Light Therapy Research Reports Encouraging Findings for Parkinson’s Patients on Medications

For the past half century the “gold standard” treatment for Parkinson’s disease has been to replace dopamine that is presumed deficient with medicines and supplements. Let’s face it. After 50 years, these treatment protocols have shown limited efficacy and, unfortunately, can be accompanied by troubling side effects. Many who have elected these such treatment strategies have experienced an impoverished quality of life in the long run.

The challenges confronted by millions of persons with neurological challenges has motivated and inspired me to pursue investigations of other approaches that fall outside traditional treatment protocols.  One such approach that shows initial promise is light (or photobiomodulation) therapy.

Researchers have recently found evidence that light therapy is a promising therapy for persons experiencing the symptoms of Parkinson’s disease. The retina is believed to play a pivotal  role in the nigrostriatal dopamine system.  Light (obviously) passes through the eyes and shines on the retina which happens to be a close neighbor of the substantia nigra, the organ positioned in the middle of the brain.  I have drawn the logical conclusion is that – Duh – light should of course make a difference!

Light Therapy Research

A study by researchers at the Bronowski Clinic in Australia conducted a longitudinal study of 129 patients diagnosed with Parkinson’s disease. Subjects who were classified as compliant – meaning they used light therapy regularly – exhibited significant improvement over subjects that were partially compliant or non-compliant.

An encouraging observation of the compliant subjects was that the drug burden was less with fewer side effects. These results suggest that light therapy shows promise as a therapy to address symptoms of Parkinson’s and a therapy which might potentially reduce the role of medications to suppress symptoms.

I interviewed the inventor of a type of new photobiomodulation therapy called the Vielight Neuro Gamma device. While there is little systematic evidence that specifically addresses symptoms of Parkinson’s for this particular device, it is a therapy that certainly merits further review and consideration in light of the early research evidence on the merits of light therapy. Since diffuse light does not easily pass through the skull, Dr. Lim’s had the brilliant idea to pass the light through a device clipped to the nose. Now, in my book of creativity, that is inventiveness at its best!

Click the image below to hear the interview and learn more about Dr. Lim’s new photobiomodulation device called the Vielight Gamma.

Vielight photobiomodulation therapy

 

It would seem at this early stage that you cannot go wrong to be open to allow light to shine brightly on the surface of your body and of course your retina!

What has been the experience of persons with Parkinson’s symptoms who have been using the Vielight Gamma Device?

Thus far, sixty-one (61) persons who listened to my interview on the Vielight device purchased the unit using the 10% coupon code (healing4me) Dr. Lim provided to listeners of my Parkinsons Recovery Radio Show interview. Those who acquired the device were invited to return the device to the company after using it for six months if it did not offer relief from their symptoms they were looking for and receive an 80% refund.

More information is available here: https://www.vielight.com

The company reported to me that 15% of the Neuro Gamma unites were returned. One loose estimate of effectiveness is that approximately 85% of users are satisfied it helps address some symptoms. The odds are certainly in your favor that the device will offer relief from symptoms. Know also that it clearly does not help everyone.

I have also heard from a member of my audience who lives in Ecuador who is connected with a wide community of persons with Parkinson’s symptoms. He reports that virtually all users experienced welcome relief from some symptoms. For some, the most pronounced results were seen in the initial 4 months or so, after which the improvements tended to level off.

Anecdotal Reports about the Vielight Photobiomodulation Neuro Device as a Treatment for Parkinson’s Symptoms

As a new invention. there is no systematic published research on the use of the Vielight Gamma Photobiomoduatlion device as a therapy to specifically address Parkinson’s symptoms. I have heard informal feedback from users who are members of my audience that the therapy has resulted in relief of some symptoms and report below my summary observations:

  1. One common report from users is that the therapy does not show quick results. You apparently have to apply the therapy over a period of several weeks to a month or longer to celebrate a positive shift in symptoms.
  2. I have heard several specific reports on tremors that were calmed.
  3. It is unclear at this point to what degree the therapy will address balance issues, but I have heard it seems to offer help with gait issues.
  4. Evidence does suggest that this therapy can potentially help with dementia.
  5. One user reported a definite return of smell, but the jury was out on the effect on tremors and other symptoms.
  6. The wife of one 85 year old man with advanced Parkinson’s symptoms reported that after 6 weeks of using the Vielight Neuro device. there were no major improvements but several minor ones of some consequence: Her husband reports being more alert, sleeping better, his cough is less, he has been inspired lately to use his automatic peddler and his hallucinations have dwindled. She reports it has been an answer for a better quality of life for both of them and promises to keep me updated.

Of course, it is difficult for people diagnosed with Parkinson’s to attribute an improvement in symptoms directly to the Vielight photobiomodulation therapy when they are taking advantage of other therapies at the same time.  Reports above are a general summary of the informal feedback I have received in emails and phone conversations. One person told me it did not offer them the relief they had expected and returned the unit.

Like virtually all natural therapies I have documented over the past 14 years, the Vielight Neuro Gamma device will not help everyone. Odds do appear to be in your favor if you decide to try it out.

Robert Rodgers PhD
Road to Recovery from Parkinsons Disease
https://www.parkinsonsdisease.me

$5 ketone Ester Trial Sample Bottle Available Today 

I just saw an announcement about a $5 trial bottle of ketone ester in my own email today. Early reports on the ketone ester for addressing Parkinson’s symptoms have been very encouraging. Can it help you or your loved one? You will not know until you try it out.

Today is a golden opportunity to find out if taking the new ester will offer relief from your symptoms. The ketone ester company linked below is making available a trial bottle of ketone ester for only $5. I would suggest you get two bottles. One may not be sufficient to see it if helps. You will need to take to entire contents to see if it helps. Visit the website below to order:

https://ketoneaid.com/pr

P.S. They only have 200 bottles to sell and the offer is open for today only. As a new therapy, we have little evidence on this. But, the early reports tell me it is worth giving it  try for sure.

Robert Rodgers PhD
Road to Recovery from Parkinsons Disease
https://www.parkinsonsdisease.me

Is Parkinson’s Disease Degenerative?

This is the question I am asked every week by someone…Listen to the audio for the answer …
The Parkinsons Recovery 2018 holiday survey was designed to answer this question. Listen to the replay of this program for details about the various natural therapies that survey respondents reported helped them feel better.

Are people diagnosed with Parkinson’s disease better, about the same or worse since last Christmas? More specifically, what therapies help people get relief from their symptoms? Answers to these questions are revealed and discussed in detail.

Most people believe that Parkinson’s disease is degenerative. Is this really true? The annual Parkinsons Recovery survey answers this very question. This program summarizes the findings.

The 2018 survey asks a simple question: have you been better, the same or worse since a year ago. Also discussed were therapies that were helpful.

Interested in more information about a therapy reported to have been helpful? Dates of Parkinsons Recovery radio show Interviews are listed below that discuss these therapies. The radio show page is:

https://www.blogtalkradio.com/parkinsons-recovery

This Parkinsons Recovery Radio show website posts more than 11 pages of programs containing about 20 interviews on each page. To locate the replay of a program, scroll down the first page or scroll back pages to locate the date the program listed below was aired. All programs are listed on the radio show website are presented in the order they were aired from 2009 until today. Therapies below are listed in alphabetic order.

Amino Acid Therapy: January 5, 2018
Aquas: August 21, 2016
Ayurveda: July 10, 2013
BEMER- Electromagnetic Therapy February 19, 2018.
CBD Oil: July 19, 2018
Emotional Freedom Technique: August 25,2015
Exercise: May 22, 2003
Ketone Diet: December 13, 2017 `
Light Therapy (Vielight):October 4, 2017
Meditation: September 24, 2009
Niacin Therapy (B1): May 23, 2018
Physical Therapy: June 10, 2010, October 11, 2018, February 18, 2015
QiGong: June 6, 2012, June 15, 2011, May 18, 2015
Tai Chi: August 6, 2009, December 3, 2009
Yoga: July 25, 2014, September 19, 2013

For information about the December 2018 Jump Start to Recovery visit:
https://www.parkinsonsrecovery.com/jump-start-to-recovery

Robert Rodgers PhD
Road to Recovery from Parkinsons Disease
https://www.parkinsonsdisease.me

Why Do People Die?

How about the title to this post – why do people die? It was inspired by my interview today posted above on Parkinsons Recovery Radio with Willem Visser, a craniosacral therapist. Now, a big part of his presentation was to explain more about what craniosacral therapy is and why it helps with symptoms of Parkinson’s disease. Some of you who receive regular craniosacral treatments may well conclude that you do not need to take 30 minutes out of your day to listen to this particular Parkinsons Recovery interview that I hosted today.

Well, might I encourage you to listen anyway. Why? Willem summarizes the work of Aubrey de Grey, an engineer, who is now focused on answering the question posted in the title above. Now, the interesting twist to Aubrey de Grey’s work is that he argues it is possible to live very long lives – up to 200 to 300 years. How could that be possible?

Listen to the interview. Your interest will be tickled too. (hint: it all has to do with cellular death).

Robert Rodgers PhD
Road to Recovery from Parkinsons Disease
https://www.parkinsonsdisease.me
Olympia Washington

Apoptosis and Parkinson’s Disease

John Rollins PhD discusses the critical role that is played by Apoptosis and why it has such a critical influence on nervous system health.  What is Apoptosis? It is the body’s natural process for repairing, regenerating and destroying damaged cells. Dozens of studies on Apoptosis are being published every day. It is one of the most researched topics out there right now.

Why is that?  Researchers (including myself) have just realized that understanding Apoptosis offers a genuine understanding about what the body needs to heal at the cellular level. What is the bottom line of this understanding?

Most of us actually do not have access to some of the foods that are needed for cells to rejuvenate and regenerate. This explains why so many people who have launched an A+ recovery program have still not succeeded in reversing all of their symptoms.

Dr. Rollins discusses these issues in detail and offers a little history lesson about his longtime relationship with Dr. Bill McAnalley who was a recent guest on Parkinsons Recovery Radio and founder of Aroga.

Dr. Rollins explains how Aroga products and in particular the Core Pathways, Brain and Nerve Plus and Aloe 1 support and nurture neural tissue health. For more information about Aroga food products click on the link below.

https://arogalife.com/parkinsons-recovery

Robert Rodgers PhD
Road to Recovery from Parkinsons Disease
https://www.parkinsonsdisease.me

Food Can Fix Things that Drugs Cant

Click the arrow below to hear my interview with Bill McAnalley PhD who discusses why food can fix things that drugs can’t. His discussion focuses on explaining the causes of Parkinson’s and lists the foods needed to treat each cause.

Information about Dr. McAnballey’s company, is accessed by visiting  Aroga

Below are the talking points that Dr. McAnalley prepared for my  interview with him on Parkinsons Recovery Radio where he explains why food can fix things drugs cant  

Parkinson’s disease (PD), characterized with bradykinesia, static tremor, rigidity and disturbances in balance, is the second most common neuro-degenerative disorder.  Alzheimer disease is first.

With the global trends in aging, the incidence of PD has increased year by year and the prevalence rate is up to 1–2% among the elderly over the age of 65 years. So far, there is still no exact cure for PD due to its diversity of etiology and complexity of symptoms.

Currently, Parkinson’s disease is treated with Levodopa and maybe Monamine, Oxidase Inhibitors (MOAs) or Acetylcholine inhibitors. Levodopa makes more Dopamine available for the dopamine receptor, MOAs increase the amount norepinephrine, dopamine and serotonin at their prospective receptors and acetylcholine inhibitors make more acetylcholine available to its receptor.

None of which address the physical cause of the disease.

The cause of PD has not been completely elucidated, but it has been generally acknowledged that the improvement of oxidative stress is one of the most important patho-physiological mechanisms.

Dr. Bill’s research has focused on stopping the causes of diseases like Parkinson’s by:

  • The inhibition of oxidative stress:

PD patients are in a state of oxidative stress. Oxidative stress is caused by the increase of free radicals in the organism, while the ability to eliminate free radicals is decreased at the same time. A large amount of lipid peroxide, such as Malondialdehyde (MDA), hydroxyl, carbonyl, etc., will cause cell death, which leads to neuronal apoptosis ultimately.

The mitochondria is the “power plant” and “energy conversion station” of cells. It also regulates the process of gene expression and apoptosis. Recent reports have suggested that mitochondrial dysfunction is closely related to a variety of neuro-degenerative diseases including PD.

  • The reduction of toxic Excitatory Amino Acids (EAA): 

Glutamate (Glu), Also, gamma-aminobutyric acid (GABA) and enkephalin can can produce excitotoxicity effects on nerve cells. Glutamate creates an excitatory effect on nerve cells, and is toxic when Dopa Amine neurons are fully or partially degenerated.

  • The inhibition of neuroinflammation:

Neuroinflammation is a common and important pathological mechanism in nervous system diseases and different neurological diseases are involved in neuroinflammation at some stage. At present, it is believed that neuroinflammation was involved in an important cascade reaction in neuronal degeneration of PD.

When the central nervous system suffers from exogenous antigens stimulus, such as pathogenic microorganisms or foreign bodies, microglia will be rapidly activated. Then, the activated microglia cells can secrete various cytokines such as IL-1β, IL-2, IL-4, IL-6, TNF-α, and IFN-γ, etc. The cytokines cause neuroinflammation.

  • The inhibition of neuronal apoptosis:

Parkinson’s is caused by the premature death of dopaminergic neurons by abnormal apoptosis activation. Energy for normal activities of brain cells comes directly from aerobic energy, and there is little energy storage. However once brain damage occurs, it will cause nerve cell apoptosis or death.

The Bcl-2 family of proteins regulate apoptosis. It is divided into two categories: anti-apoptosis gene (such as Bcl-2, Bcl-xL, Bcl-w, Bcl-1, etc.) and pro-apoptosis gene (such as Bax, Bak, Bad, Bid, etc.). Their ratio regulates apoptosis.

  • The inhibition of abnormal protein aggregation:

Misfolded and aggregated proteins play a key role in the pathogenesis of Parkinson’s Disease. Protein aggregates differ from disease to disease. This common characteristic shows that protein deposition is toxic to neurons.

Studies confirmed that the activity of the proteasome dropped substantially in substantia nigra of patients with PD, which weakened the ability of the substantia nigra to degrade α-syn and other proteins.

  • Targeting Nrf2 to Suppress Ferroptosis and Mitochondrial Dysfunction in Neurodegeneration:

Nrf2 is a basic leucine zipper (bZIP) protein that regulates the expression of antioxidant proteins that protect against oxidative damage triggered by injury and inflammation. Several drugs that stimulate the NFE2L2 pathway are being studied for treatment of diseases that are caused by oxidative stress.

Listing of Core Food Ingredients that Address the Structure and Functional Causes of the Disease

  1. The inhibition of oxidative stress:

Brahmi, Bacopa monnieri

Maca root powder, Lepidium meyenii (Walp.)

Tongkat Ali (Longjack), Eurycoma Longifolia

Turmeric root powder, Curcuma longa

  1. The reduction of toxic Excitatory Amino Acids EAA:

Brahmi, Bacopa monnieri

  1. The inhibition of neuroinflammation:

Turmeric root powder, Curcuma longa

Wild Yam root, Dioscorea villosa

  1. The inhibition of neuronal apoptosis:

Noni Fruit, Morinda citrifolia

  1. The inhibition of abnormal protein aggregation:

Amia powder, Emblica officinalis

Turmeric root powder, Curcuma longa

  1. Targeting Nrf2 to Suppress Ferroptosis and

Mitochondrial Dysfunction in Neurodegeneration.

Chaga Mushroom, Inonotus Obliquus

Milk Thistle Seed Extract, Silybum marianum.

Tongkat Ali (Longjack), Eurycoma Longifolia

Aroga

Dr. Bill offered suggestions on the products he recommended for persons diagnosed with Parkinson’s.  He recommended three
Aroga products: (1) the Core (2) the Plus Brain and Nerve and (3) the Bone, Joint and Endocrine (which supports hormones). At a minimum. the Core would take top priority.

Information about these products and the opportunity to order is available at:

https://arogalife.com/parkinsons-recovery

Sadly, Aroga products can only be shipped to locations in the United States.

Robert Rodgers PhD
Road to Recovery from Parkinsons Disease
https://www.parkinsonsdisease.me

References:

Front Pharmacol. 2017; 8: 634. The Mechanisms of Traditional Chinese Medicine Underlying the Prevention and Treatment of Parkinson’s Disease.

Front Neurosci. 2018 Jul 10;12:466. Targeting Nrf2 to Suppress Ferroptosis and Mitochondrial Dysfunction in Neurodegeneration.